SPREAD AND PRIMARY MANIFESTATIONS OF ROTAVIRUS INFECTION MORBIDITY IN DIFFERENT PARTS OF THE WORLD
https://doi.org/10.15690/pf.v10i4.753
Abstract
The article presents data on the peculiarities of the rotavirus infection spreading in the Russian Federation and other certain countries. It is shown that morbidity levels depend on both objective (population size and territory density, transmission paths activity) and subjective (detectability levels) factors. It has been established that children 0-3 years of age are the most susceptible to rotavirus infection. The epidemic process development intensity is higher in bigger cities. Considerable regional and seasonal changeability of circulating rotavirus strains is noted.
About the Authors
V. V. Kudryavtsev
First Sechenov Moscow State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
graduate student at the epidemiology and evidence-based medicine department of the medical-preventative faculty of the SBEI HPE “The First Sechenov MSMU” of the Russian Ministry of Health
Russian Federation
graduate student at the epidemiology and evidence-based medicine department of the medical-preventative faculty of the SBEI HPE “The First Sechenov MSMU” of the Russian Ministry of Health
A. Y. Mindlina
First Sechenov Moscow State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
A. N. Gerasimov
First Sechenov Moscow State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
T. P. Grunicheva
Territorial Administration of the Federal Service on Customers’ Rights Protection and Human Well-Being Surveillance
Russian Federation
Russian Federation
A. N. Kaira
Interregional Administration № 1 of the FMBA of Russia, Moscow
Russian Federation
Russian Federation
N. I. Briko
First Sechenov Moscow State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
References
1. Parashar U. D., Gibson C. J., Bresee J. S., Glass R. I. Rotavirus and severe childhood diarrhea. EID. 2006; 12 (2): 304–306.
2. Parashar U. D., Burton A., Lanata C., Boschi-Pinto C., Shibuya K., Steele D., Birmingham M., Glass R. I. Global mortality associated with rotavirus disease among children in 2004. JID. 2009; 200: 9–15.
3. Tate J. E., Burton A. H., Boschi-Pinto C., Steele A. D., Duque J., Parashar U. D. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programs: a systematic review and meta-analysis. Lancet. 2011; 12 (2): 136–141. Doi: 10.1016/S1473-3099 (11)70253–5.
4. Rotavirus vaccines. WHO position paper. 2013; 5 (88): 49–64. URL: http://www.who.int/wer
5. Iturriza-Gomara M., Dallman T., Banyai K. Rotavirus surveillance in Europe, 2005–2008: Web-enabled reporting and real-time analysis of genotyping and epidemiological data. JID. 2009; 11: 215–221. Doi: 10.1086/605049.
6. Эпидемиологический надзор, лабораторная диагностика и профилактика ротавирусной инфекции (утв. Главным государственным санитарным врачом РФ). Методические указания (МУ 3.1.12957-11). М., 2011.
7. Сагалова О. И. Клинико-иммунологическая характеристика кишечных инфекций вирусной этиологии у взрослых. Автореф. дис. … докт. мед. наук. М., 2009.
8. Профилактика инфекционных заболеваний. Профилактика острых кишечных инфекций. Санитарно-эпидемиологические правила (СП 3.1.1.1117-02). М., 2002.
9. Velazquez F. R., Matson D. O., Calva J. J., Guerrero L., Morrow A. L., Carter-Campbell S., Glass R. I., Estes M. K., Pickering L. K., Ruiz-Palacios G. M. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med. 1996; 335: 1022–8.
10. Vesikari Т. et al. Rotavirus vaccination: a concise review. Clinical microbiology and infection diseases. 2012; 18 (Suppl. 5): 57–63.
11. Cunliffe N. A., Kilgore P. E., Bresee J. S., Steele A. D., Luo N., Hart C. A., Glass R. I. Epidemiology of rotavirus diarrhea in Africa: a review to assess the need for rotavirus immunization. Bull World Health Organ. 1998; 76 (5): 525–537.
12. Levy K., Hubbard A. E., Eisenberg J. N. S. Systematic reviews. Seasonality of rotavirus disease in the tropics: a systematic review and meta-analysis. Int J Epidemiol. 2009; 38 (6): 1487–1496. Doi: 10.1093/ije/dyn260.
13. Dey A., Wang H., Menzies R., Macartney K. Changes in hospitalisations for acute gastroenteritis in Australia after the national rotavirus vaccination program. Med J Aust. 2012; 197 (8): 453–457. Doi: 10.5694/mja12.10062.
14. Kirkwood C. D., Boniface K., Bogdanovic-Sakran N., Masendycz P., Barnes G. L., Bishop R. F. Rotavirus strain surveillance — an Australian perspective of strains causing disease in hospitalized children from 1997 to 2007. Vaccine. 2009; 27 (5): 102–107. Doi: 10.1016/j.vaccine.2009.08.070.
15. Близнюк А. М., Петровская О. Н., Запольская В. В., Рашкевич И. И., Чистенко Г. Н., Фисенко Е. Г. Проявления эпидемического процесса ротавирусной инфекции в г. Минске. Медицинский журнал. 2011; 2: 129–131.
16. Podkolzin A. T., Fenske E. B., Abramycheva N. Y., Shipulin G. A., Sagalova O. I., Mazepa V. N., Ivanova G. N., Semena A. V., Tagirova Z. G., Alekseeva M. N., Molochny V. P., Parashar U. D. Hospital-Based surveillance of rotavirus and other viral agents of diarrhea in children and adults in Russia, 2005–2007. The Journal of Infectious Diseases. 2009; 200: 228–33.
17. Подколзин А. Т., Петухов Д. Н., Веселова О. А. Отчет РЦКИ. Данные о циркуляции ротавирусов группы А в РФ в зимний сезон 2011–2012 гг. Публикация Референс-центра по мониторингу возбудителей кишечных инфекций доступна на интернет странице центра (www.epid-oki.ru). ФБУН ЦНИИ эпидемиологии Роспотребнадзора, РЦКИ. Москва. 2012.
18. Country National Immunization Program (NIP). URL: http://sites.path.org/rotavirusvaccine/files/2012/12/PATH_Country-Introduction-Interactive-Spreadsheet_EN.pdf
19. Kirkwood C. D., Boniface K., Barnes G. L., Bishop R. F. Distribution of rotavirus genotypes after introduction of rotavirus vaccines. Rotarix (R) and RotaTeq (R), into the national immunization program of Australia. Pediatric Infectious Disease Journal. 2011, 30: 48–53.
20. Cortes J. et al. Ротавирусная вакцина и потребность в медицинской помощи по поводу диареи у детей в США. N Engl J Med. 2011; 365: 1108–17.
21. Lopman B. A., Curns A. T., Yen C., Parashar U. D. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. The Journal of Infectious Diseases. 2011; 204: 980–6.
22. Glass R. Unexpected benefits of rotavirus vaccination in the United States. The Journal of Infectious Diseases. 2011; 204: 975–7.
23. Zeller M., Rahman M., Heylen E., De Coster S., De Vos S., Arijs I., Novo L., Verstappen N., Van Ranst M., Matthijnssens J. Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine. 2010; 28 (47): 7507–7513. Doi: 10.1016/j.vaccine.2010.09.004.
Review
For citations:
Kudryavtsev V.V., Mindlina A.Y., Gerasimov A.N., Grunicheva T.P., Kaira A.N., Briko N.I. SPREAD AND PRIMARY MANIFESTATIONS OF ROTAVIRUS INFECTION MORBIDITY IN DIFFERENT PARTS OF THE WORLD. Pediatric pharmacology. 2013;10(4):38-44. (In Russ.) https://doi.org/10.15690/pf.v10i4.753
Views:
1100
Email this article 